Tirzepatide, a dual GLP-1/GIP receptor agonist, is an injectable prescription medicine FDA approved for Type 2 diabetes treatment (Mounjaro) and weight management (Zepbound).
Compounded Tirzepatide, if it is made to be “essentially a copy”, has the same efficacy and side effects as a commercial counterpart for a fraction of the cost.
In this article we will discuss Compounded Tirzepatide dosage and administration, potential side effects, safety and legality and how to choose a reliable Compounding pharmacy.